Price $0.99 |
Market Cap
26.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
5.07
|
P/S
22.49
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-900
|
FCF
-
|
|
Op. Margin
-112.10%
|
Net Margin
-184.90%
|
ROE
-37.30%
|
ROI
-1.80%
|
|
ROA
-14.20%
|
EPS Growth
35.00%
|
Current Ratio
0.7
|
Debt/Equity
71.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Co (BMY) | $68.73 | - | 2.90% | 148.62B | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $6.53 | - | - | 15.2M | Strong Buy |
| Genesis Healthcare Inc (GENN) | $0.25 | - | - | 53.6M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.80 | - | - | 97.6M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $4.95 | - | - | 1.59B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
